-
-
-
[1] Zhang L, Shi M, Huang C, et al. A phase Ⅱ, multicenter, placebo-controlled trial of apatinib in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) after two previous treatment regimens[J]. J Clin Oncol, 2012, 30(15 Suppl): 7548. http://meetinglibrary.asco.org/content/69454?media=vm&poster=1 [2] 李旭, 张翠翠, 谭红叶, 等.甲磺酸阿帕替尼片治疗晚期非小细胞肺癌的临床效果观察[J].中国生化药物杂志, 2016, 2:91-93. http://www.cqvip.com/QK/97426A/201602/668405852.htmlLi Xu, Zhang Cuicui, Tan Hongye, et al. Observe the clinical effect of apatinib mesylate tablets in the treatment of advanced non-small cell lung cancer[J]. China Journal of Medicine, 2016, 91-93. http://www.cqvip.com/QK/97426A/201602/668405852.html